Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Genomic Testing Would Benefit From Traceability, Standardization – Mayo's Klee

This article was originally published in The Pink Sheet Daily

Executive Summary

Manufacturers that participate in developing reference standards will have an advantage, Klee says. An FDA Rx/diagnostic co-development guidance is expected this year.

You may also be interested in...

Medtronic, Genzyme Team Up To Develop Cellular Cardiac Therapy

Genzyme expects to complete enrollment of its Phase II myoblast cardiac therapy trial by late 2006. While the clinical trials are ongoing, the company will outfit Medtronic’s TransAccess catheter for myoblast delivery. CBER likely would review the combination product.

FDA Sets Parameters For Combination Product Dispute Resolution

Requests related to the timeliness of premarket reviews should be filed only after applicable performance goal timelines have passed, an agency draft guidance states.

GE Healthcare Joins Personalized Medicine Fray, Seeks Drug Firm Alliances

Amersham protein separation technology is key to GE Healthcare's personalized medicine venture, likely to lead to drug R&D deals in diagnostic/therapy combinations. GE Healthcare projects $16 bil. in 2005 revenue.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts